Objective: At present there is no clear, cohesive, and comprehensive theoretical understanding of the role of core beliefs in the development of disordered eating. The present study aimed to develop and test a theoretical model outlining important processes and pathways from core beliefs to eating disorder (ED) behaviours. It also aimed to explore potential differences (or similarities) in contributions of four core belief dimensions to the development and maintenance of ED symptomatology.
View Article and Find Full Text PDFMeasurement of internal intervertebral disc strain is paramount for understanding the underlying mechanisms of injury and validating computational models. Although advancements in noninvasive imaging and image processing have made it possible to quantify strain, they often rely on visual markers that alter tissue mechanics and are limited to static testing that is not reflective of physiologic loading conditions. The purpose of this study was to integrate high-frequency ultrasound and texture correlation to quantify disc strain during dynamic loading.
View Article and Find Full Text PDFIntroduction And Aim: Diabetes is a global health emergency with increasing prevalence and diabetes-associated morbidity and mortality. One of the challenges in optimising diabetes care is translating research advances in this heterogeneous disease into clinical care. A potential solution is the introduction of precision medicine approaches into diabetes care.
View Article and Find Full Text PDFMaine is a largely rural state where nearly half of the population uses drinking water from private wells. Arsenic (As) is present in some Maine groundwater, has been linked to cancer, and a lack of testing and treatment may expose people with private wells to elevated As levels. Disinfection byproducts (DBPs) include known and suspected carcinogens that form when chlorine or chloramines are added to water.
View Article and Find Full Text PDFObjectives: The purpose of this study was to describe the enoxaparin dose required by preterm neonates and infants to achieve therapeutic anti-Xa levels.
Study Design: Retrospective chart review of preterm infants, <12 weeks postnatal age, born before 37 weeks gestation, receiving subcutaneous (SUBQ) enoxaparin every 12 h (q12h) with an anti-Xa goal of 0.5-1 units/mL.